Amgen (AMGN) Tops Q1 EPS by 7c; offers guidance
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $383.74 +1.04%
EPS Growth %: +2.7%
Financial Fact:
Other charges: 23M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +2.7%
Financial Fact:
Other charges: 23M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.96, $0.07 better than the analyst estimate of $3.89. Revenue for the quarter came in at $7.45 billion versus the consensus estimate of $7.45 billion.
GUIDANCE:
Amgen sees FY2024 EPS of $19.00-$20.20, versus the consensus of $19.53. Amgen sees FY2024 revenue of $32.5-33.8 billion, versus the consensus of $32.956 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lumentum shares rise on analyst upgrades, AI demand outlook
- Amgen (AMGN) PT Lowered to $430 at UBS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
